Romerr Alao
Papers
2
Total Citations
5
H-Index
1
About
Romerr Alao is a rising urological surgeon and researcher whose work is centered on improving outcomes for patients with muscle-invasive bladder cancer (MIBC). His research critically examines the surgical management of this aggressive disease, focusing on the nuances of radical cystectomy (RC) and its alternatives. Alao’s major contributions include identifying contemporary trends and predictors of adverse pathological upstaging in clinical T2 MIBC patients undergoing RC, a finding that directly challenges the safety of bladder-sparing strategies like trimodality therapy for certain subgroups. His work on the timing of urethrectomy—comparing delayed versus concomitant procedures—provides vital perioperative and survival data to guide surgical decision-making. Though early in his career, his most cited paper (4 citations) from 2025 has already established a foundation for risk-stratifying patients to optimize treatment selection. By leveraging a large, single-tertiary-center UK cohort, Alao delivers real-world evidence that refines clinical guidelines. His focus on pathological upstaging and surgical sequencing marks him as a meticulous investigator dedicated to enhancing the precision and safety of bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2